BD Completes Acquisition of Safety Syringes
BD (NYSE: BDX), a leading global medical technology company, announced today that it has completed its acquisition of Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. The financial terms were not disclosed.
The acquisition broadens BD's healthcare worker safety offering to include passive safety technologies for any prefillable syringe customer.
"We believe the Safety Syringes product line is a valuable asset to BD and aligns well with our focus on healthcare worker safety, and offering higher-value products," said Claude Dartiguelongue, President, BD Medical - Pharmaceutical Systems. "We are excited about this acquisition, which expands the Company's presence in safety technologies and further demonstrates BD's commitment to developing innovative solutions that help address our customers' unmet needs. We are pleased to welcome this new product portfolio and these new associates to BD."
BD expects the transaction to be minimally dilutive for fiscal year 2013, and does not expect it to impact BD's previously communicated 2013 earnings guidance.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.